Oncology & Cancer
Approved drug may be repurposed to treat tumors resulting from NF2-related schwannomatosis
Patients with a genetic syndrome called NF2-related schwannomatosis (NF2-SWN) have tumors that develop on the covering of the brain or grow along the nerves in the brain, spinal cord, and/or other locations in the body.
Jun 24, 2024
0
18